Animal Models for the Study of the Relationships between Diet and Obesity: A Focus on Dietary Protein and Estrogen Deficiency by Tristan Chalvon-Demersay et al.
March 2017 | Volume 4 | Article 51
Review
published: 20 March 2017
doi: 10.3389/fnut.2017.00005
Frontiers in Nutrition | www.frontiersin.org
Edited by: 
Sergueï O. Fetissov, 
University of Rouen, France
Reviewed by: 
Alessandro Laviano, 
Sapienza University of Rome, Italy 
Troy A. Roepke, 
Rutgers-New Brunswick, USA
*Correspondence:
Anne Blais 
blais@agroparistech.fr
Specialty section: 
This article was submitted to 
Clinical Nutrition, 
a section of the journal 
Frontiers in Nutrition
Received: 22 November 2016
Accepted: 01 March 2017
Published: 20 March 2017
Citation: 
Chalvon-Demersay T, Blachier F, 
Tomé D and Blais A (2017) Animal 
Models for the Study of the 
Relationships between Diet and 
Obesity: A Focus on Dietary Protein 
and Estrogen Deficiency. 
Front. Nutr. 4:5. 
doi: 10.3389/fnut.2017.00005
Animal Models for the Study of the 
Relationships between Diet and 
Obesity: A Focus on Dietary Protein 
and estrogen Deficiency
Tristan Chalvon-Demersay, François Blachier, Daniel Tomé and Anne Blais*
UMR Physiologie de la Nutrition et du Comportement Alimentaire, AgroParisTech, INRA, Université Paris-Saclay,  
Paris, France
Obesity is an increasing major public health concern asking for dietary strategies to limit 
weight gain and associated comorbidities. In this review, we present animal models, 
particularly rats and mice, which have been extensively used by scientists to understand 
the consequences of diet quality on weight gain and health. Notably, modulation of 
dietary protein quantity and/or quality has been shown to exert huge effects on body 
composition homeostasis through the modulation of food intake, energy expenditure, 
and metabolic pathways. Interestingly, the perinatal window appears to represent a 
critical period during which the protein intake of the dam can impact the offspring’s 
weight gain and feeding behavior. Animal models are also widely used to understand 
the processes and mechanisms that contribute to obesity at different physiological 
and pathophysiological stages. An interesting example of such aspect is the situation 
of decreased estrogen level occurring at menopause, which is linked to weight gain 
and decreased energy expenditure. To study metabolic disorders associated with such 
situation, estrogen withdrawal in ovariectomized animal models to mimic menopause 
are frequently used. According to many studies, clear species-specific differences exist 
between rats and mice that need to be taken into account when results are extrapolated 
to humans.
Keywords: animal models, obesity, body composition, dietary protein, food intake, energy expenditure, estrogen 
deficiency
iNTRODUCTiON
Obesity is a worldwide epidemic affecting over 400 million adults with serious comorbidities (1). 
Obesity develops when energy consumption exceeds energy expenditure and is defined as the 
accumulation of excess body fat to the extent that its results in health complications and reduces 
life expectancy (2). As obesity prevalence is rising, the quest to find new treatments to diminish its 
negative consequences is also increasing. Experimental research needs to determine the mechanisms 
by which obesity increase the risk of diseases. To investigate the interactions between the compo-
nents of the diet and the biological processes, epidemiological, experimental, and clinical studies 
are necessary.
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Regarding experimental studies, animal models are essential 
for in vivo and ex vivo experimental design. Nutrient and non-
nutrient components of food interact with many metabolic 
pathways at different levels including gene expression regulation. 
Experimental models, from cells to organoids and animals, are 
also essential to elucidate mechanisms by which food compo-
nents can modulate metabolic pathways. To be able to translate, 
at least partly, the information obtained from an animal model to 
humans, the choice of the appropriate animal model is a crucial 
step to avoid as much as possible misinterpretations.
Dietary interventions studies in animals are thus essential 
to understand the biological roles of specific nutrients before 
validation in human. In the last century, rats were the most used 
in biochemical research, but in the last two decades, its popular-
ity decayed due to the limitation to perform reverse genetics in 
rats. Mus musculus is probably the most popular model used to 
identify the mechanisms of food intake and energy regulation. 
Even if some extrapolation from mice to humans is hazardous, 
the mice model has helped us to develop some therapies for obe-
sity, metabolic syndrome, and insulin resistance (3). If mouse 
models obviously do not mimic all aspects of human diseases, 
they are, however, the most commonly used models. No other 
animal model offers such large possibilities of phenotyping in 
response to metabolic, genetic, and behavioral manipulations. 
Depending on the target, the most widely used mouse models 
are (i) spontaneously occurring obese mouse strains that are 
well characterized, (ii) high-fat diet that rapidly induce weight 
gain in mice, and (iii) transgenic or gene knockouts mice to 
determine the influence of a given gene in the development of 
obesity.
Animal models have thus been used extensively by the scien-
tific community to understand the role of diet quality on health. A 
better understanding of the relation between diet quality, and also 
physical activity and progression of chronic disease, such as obe-
sity as presented in this review article, is increasingly important 
with regard to the increase in the number of obese individuals 
worldwide.
This review will focus specifically on two typical situations 
in the rodent models: (i) the impact of protein quality/quantity 
and (ii) the impact of estrogen deficiency on body weight and 
composition. A short section on the pig model will conclude this 
article to summarize the advantages and limitation of this model 
versus the rodent models, in general terms and in terms of studies 
on obesity.
PROTeiN QUANTiTY/QUALiTY
Dietary intervention studies in animal models are essential to 
understand the biological roles of specific nutrients before valida-
tion in humans.
Dietary Protein intake
Protein is an essential dietary component in which recommended 
level is defined as the minimum intake required to maintain nitro-
gen balance; and as the amount of protein sufficient to prevent 
the catabolism of body protein stores. The recommended daily 
minimum intake of protein and amino acids (AAs) in adults is 
0.8 g/kg of body weight (4). However, recent studies using stable 
isotope suggest that current dietary protein recommendation 
may not be sufficient to promote optimal muscle physiology in 
all populations (5). Epidemiological studies support the notion 
that especially in the older population, a greater protein intake, 
up to 19% of the energy, better preserves lean body mass (LBM) 
(6). In industrialized countries, the main sources of protein 
are milk, eggs, and meat. The nutritional value of protein is 
influenced by several factors, especially the AA composition, 
protein digestibility, protein digestion kinetics, and the ability to 
transfer AA for protein synthesis. Diets based on either animal 
or vegetable products supply proteins of different quality in dif-
ferent quantities. Plant proteins are often lower in some specific 
indispensable AAs when compared to animal proteins. For 
instance, soy protein is reported as a “complete” protein, but its 
overall indispensable AA content is lower than the one measured 
in milk proteins (7). Thus, protein quality, which is defined as the 
capacity of dietary protein sources to satisfy the metabolic needs 
for protein, and as the content in essential AAs, is important 
when considering protein requirements. Correlations between 
protein nutrition and human health are becoming a highlighted 
research topic.
Low-Protein (LP) and High-Protein (HP) 
Diets
Studies have suggested that when rats are placed in food choice 
position, they regulate their protein intake, so that it corresponds 
to their nutritional needs (8). Consistent with these results, 
experiments have shown an increase in food intake when the 
diet protein content is decreased at the expense of carbohydrates 
(9). The “protein leverage hypothesis” issued by Simpson and 
Raubenheimer proposes that paradoxically, proteins, which only 
represent between 10 and 15% of the average energy intake in 
adults represent the key factor in body weight and composition 
regulation (10). These authors have observed that the ratio 
between the protein and other nutrients (carbohydrates and 
lipids) has dropped in the last years. Thus, people, according 
to their hypothesis, tend to consume more dietary proteins to 
cover their protein needs. This excessive consumption of HP and 
LP density food, may partly explain the weight gain and obesity 
measured in these individuals. This observation is in line with 
numerous animals studies showing that substitution of carbohy-
drates by proteins in HP diet reduce adiposity and food intake 
(11, 12), while LP diets are associated with an increase in food 
intake and fat mass (13–15).
Since LP and HP diets are commonly consumed, it is particu-
larly interesting to study consequences of those diets on human 
health. However, it should be underlined that the average amount 
of dietary protein consumed is generally above the recommended 
dietary intake in Western countries. For instance, in France, 
the average dietary consumption is 1.7-fold the recommended 
dietary intake (16). The consumption of HP diets, which can 
lead to the consumption of dietary protein up to four times the 
recommended dietary protein intake, are frequently used by 
individuals who wish to decrease their body weight. Although 
body weight diminution in overweight and obese individuals is 
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obviously associated with beneficial outcomes, some deleteri-
ous effects of HP diet have been suggested in several studies. 
Indeed, HP diets are contraindicated for individuals who are 
suffering or predisposed to kidney diseases (17). Regarding 
the intestinal physiology, in case of HP consumption, a part of 
dietary and endogenous proteins escapes full digestion in the 
small intestine and is transferred to the large intestine, where 
they are metabolized by the intestinal microbiota that produce, 
from AAs, various metabolites, some being beneficial, while 
most of them being deleterious when present in excess (18). An 
epidemiological analysis performed by Shoda et al. (19) in Japan 
showed a correlation between incidence of Crohn’s disease (an 
intestinal chronic inflammatory bowel disease) and increase 
intake of animal protein over a period of 20 years. A prospec-
tive cohort study carried out in women also reported a positive 
association between the level of dietary intake and risk of inflam-
matory bowel diseases (20). However, Spooren et al. have recently 
performed a systematic review of the epidemiological studies that 
have examined the links between protein intake and the risk of 
developing inflammatory bowel diseases and have reported that 
most studies performed found no significant association between 
these two parameters (21). When interpreting the results of these 
different studies, it is worth taking into consideration that, due 
to the high complexity of diet, it may appear difficult to collect 
robust dietary data. Then, it remains possible that the effects of 
the protein intake on the risk of developing inflammatory bowel 
diseases may have been biased in some studies by confounding 
factors.
Regarding the possible links between HP diet and the risk 
of colorectal cancer, the results obtained from epidemiologi-
cal and experimental studies do not allow to reach any robust 
conclusion, the results obtained being rather heterogeneous 
(22). Observational studies have reported that HP diet is linked 
with higher mortality due to cardiovascular disease (23, 24). 
However, as discussed earlier, increased protein consumption 
is commonly associated with high intake of other alimentary 
compounds like meat that contains notably heme, N-nitroso 
compounds, and heterocyclic amines, which have been reported 
to exert negative effects on various health aspects when present 
in excess. Therefore, these confounding factors do not allow to 
determine clearly the role of protein per  se on various health 
parameters.
Concerning LP diets, there is no clear definition for this type of 
diet. LP diets are often recommended for patients with anomalies 
of the AA metabolism including phenylketonuria and those with 
kidney or liver diseases (25, 26). Furthermore, in developing 
countries, children during fetal development, lactation, and after 
weaning are often fed with diets including high carbohydrate but 
LP level (27, 28). It is therefore important to determine the effects 
of LP diets on weight and body composition.
The consequences of HP and LP diets on body composition 
can be studied in animal models with no difference in energy 
content. For example, experimental HP diets usually contain 
less digestible carbohydrates but had exactly the same composi-
tion regarding lipids, undigestible carbohydrates, minerals, and 
vitamins (29). The use of animal models is suitable to reveal the 
underlying mechanisms.
Dietary Protein intake, Body weight, and 
Composition
Numerous studies have reported that HP diets allow reduction 
of adiposity while maintaining LBM in animals (30–32). In rats, 
it has been shown that HP diets, in which 50% of the energy is 
provided by proteins, drastically reduced after 6 months the white 
adipose tissue compared to a normal protein diet (30). Consistent 
with these results, Pichon et al. found that increasing protein level 
in the diet reduced weight gain more strongly than the reduction 
of carbohydrates/lipids ratio (32). Moreover, this decrease in 
weight gain was associated with decreased adipocyte size (11).
It has been shown that protein restriction can replicate the 
effects of calorie restriction over a short period of 8 weeks in mice, 
with a decrease in circulating insulin, glucose tolerance, and 
weight gain (15). However, consumption of LP diet over longer 
periods in mice is generally associated with increased weight, 
adiposity, and intrahepatic fat (14, 15). On the contrary, growing 
rats fed for 15 days with a LP diet exhibited a lower body weight 
but a greater adiposity (13), enlightening the importance of the 
dietary intervention duration.
Dietary Protein Level and Food intake
Mellinkoff, according to his aminostatic theory (33), was the first 
to hypothesize that the fluctuations of plasma AA concentrations 
could act on the control of food intake. Noting that «a rise in 
the serum amino acid concentration appears to be accompanied 
by a waning of appetite», he hypothesized that when plasma AA 
concentrations reach a threshold, satiety occurs. Furthermore, 
it is well known since several years that the AA content in the 
cerebrospinal fluid reflects circulating AA levels, itself linked to 
the dietary protein composition (34). Some of these AAs can also 
serve as precursor of neuropeptides that are directly involved in 
food intake regulation. This is the case for tryptophan, which is 
a precursor for serotonin, this latter neurotransmitter repressing 
food intake (35). Similarly, histamine is synthesized from histi-
dine, and high levels of histidine are thought to have a negative 
effect on food intake through histaminergic neurons activation 
(36). AA composition could therefore explain why some proteins 
have been reported to be more satiating than lipids and carbohy-
drates (37, 38).
Taken together, these observations support the concept that 
a HP diet decreases food intake, while a LP diet increases it. On 
the contrary, very LP diet generates an aversive phenomenon (39) 
that allows the individuals to direct its choice toward balanced 
food to maintain essential AAs homeostasis (40).
The effects of HP diets on food intake are especially observed 
during the first days after the introduction of the diet. Once 
the animals are accustomed to the HP diet, they tend to return 
to a food intake similar to the one observed in animals fed a 
control diet.
The effect of both HP and LP diet on food intake is mediated 
by gastrointestinal peptides. Thus, Batterham and colleagues 
observed an increase in the plasma levels of the anorectic pep-
tide PYY in mice following ingestion of an HP diet (41). In the 
same study, they have shown that mice deleted for the PYY gene 
no longer exhibit a decrease in food intake under a HP diet. In 
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humans, studies have reported that HP diet is also associated 
with increases in the concentrations of glucagon-like peptide-1 
(GLP-1), cholecystokinin (CCK), and a decrease in ghrelin 
concentration (42). Interestingly, LP diets are associated with 
small changes in CCK or ghrelin levels relative to control diets. 
Morrison and Laeger hypothesized that this blunted response 
may contribute to the hyperphagia observed in case of LP diet 
consumption (42).
The effect of LP diet on food intake is also mediated through 
FGF21 secretion. Indeed, the increase in food intake induced 
under a LP diet is suppressed in FGF21-KO mice (43).
Moreover, the supplementation of some AAs (histidine, 
phenylalanine, tryptophan, alanine, glutamine, and arginine) 
can partially mimic the satiating effect of HP diet on food intake 
and/or gastrointestinal peptides secretion (44–51). For example, 
oral glutamine or arginine increases the secretion of GLP-1 and 
improves glucose tolerance in rodents (50, 51). Branched AAs, 
particularly leucine, can reproduce the effects of a HP diet. 
Leucine supplementation in the diet or in the drinking water 
reduces food intake in rats and mice (46, 52). Furthermore, 
leucine icv injection, but not tryptophan, threonine, methionine, 
lysine, and serine, reduces food intake and body weight (43, 53), 
indicating that at least part of the anorectic signal induced by leu-
cine is generated centrally. Leucine and HP diet exert their effect 
via an increase of mTOR activity and a decrease of AMPK activity 
in the hypothalamus, which leads to an increase in the anorectic 
pro-opiomelanocortin and a decrease of the orexigenic NPY and 
AgRP in the arcuate nucleus of the hypothalamus (53–55).
Dietary Protein and Reorientation of 
Metabolic Pathways
Consumption of a LP diet, providing only 5–6% of the energy 
as protein, increases food intake, adiposity, and intrahepatic fat 
content compared to a control diet (14, 15). The increase of the 
hepatic lipogenesis is correlated to an increase in the SREBP-1c 
transcription factor and of glycerokinase activity by 30 and 50%, 
respectively (56). However, using diet in which 10% of the energy 
was provided by proteins, Henagan et al. found that consumption 
of a LP diet is associated with a decrease in liver lipogenesis, and 
in particular of the expression of stearoyl-coenzyme A desaturase 
(SCD-1), FAS, and SREBP-1c (57). The higher protein level used 
by Henegan may explain these conflicting results.
The triglyceride (TG) accumulation in adipocytes may also be 
related to a decrease in lipolysis. Indeed, Buzelle et al. showed that 
lipogenesis in adipocytes is usually lower under LP diet, and that 
these cells do not respond to the lipolytic action of noradrenaline 
(58). Thus, the disability to mobilize fat likely explains the accu-
mulation of TG in white adipose tissue.
As the adiposity reduction related to HP diet is partially medi-
ated by food intake reduction, it is necessary to use a pair-feeding 
group of animals to adjust the caloric intake of rats fed with a 
normo-protein diet with the one measured in rats fed with a HP 
diet (12). However, even if the rats fed with the standard diet are 
pair fed, they still exhibit a higher adiposity than the HP fed rats. 
These results support the view that the effects of HP diet involve 
the reduction of lipogenesis.
Fourteen days after the introduction of a HP diet, gene expres-
sion of FAS and ACC in the liver was suppressed (59). Moreover, 
the expression of FAS and SREBP-1c in the liver of rats fed for 
8 weeks with a HP diet compared to rats fed a NP or NP pair-fed 
diet was also reduced (11).
Studies have shown that under a normo-protein diet, all AAs 
that are deaminated are oxidized rapidly. By contrast, under a HP 
diet, only half of the deaminated AAs are oxidized, resulting in 
the generation of a “carbon skeleton reserve” in the form of α-keto 
acids (60, 61). Furthermore, high plasmatic AA level increases 
both insulinemia and glucagonemia, which stimulates gluconeo-
genesis. Indeed, several AAs, including cationic AAs, are known 
stimulators of insulin secretion (62, 63). Moreover, Veldhorst and 
colleagues observed an increase in gluconeogenesis in healthy 
men fed a HP diet (64). In rats, the increase in dietary protein 
induces the expression of PEPCK in the fasted and fed rats and 
of glucose 6-phosphatase, only in the fasted state. These results 
suggest an increase in hepatic glucose synthesis (65). Ketogenesis 
is another metabolic pathway by which the carbon skeletons 
derived from the AA deamination can be managed. In fact, in 
humans and animals, an increase in circulating ketone body 
levels (especially β-hydroxybutyrate) was observed in response 
to HP diet ingestion (64). Finally, HP diets also allow a renewal of 
glycogen stores and an increase in the conversion of dietary AAs 
into glycogen (60, 66, 67).
Dietary Protein and energy expenditure
Postprandial thermogenesis is defined as the increase in energy 
expenditure after a meal or after ingestion of a given nutrient. This 
parameter results from the energy cost corresponding to absorp-
tion, digestion, and metabolism of nutrients provided by the meal. 
In humans, it has been shown that postprandial thermogenesis is 
in the range of 15–30% of the ingested energy for protein, while 
for carbohydrates and lipids this value is, respectively, between 
5 and 10% and 0 and 3% (68, 69). Mikkelsen et al. showed that 
when protein energy contribution in meal is increased from 11 
to 29%, the energy expenditure is also increased of about 10% per 
day (70). The increase in energy expenditure associated with the 
consumption of protein may partly explain their satiating effect. 
Indeed, several authors have suggested that increased metabolism 
had an inhibitory effect on food intake (71, 72).
Recent studies report that in mice fed with LP or HP diets, 
the postprandial thermogenesis is increased compared to normo-
protein diet (73). Similar results are reported for total energy 
expenditure (14, 74, 75). In line with these results, it has been 
shown that the basal temperature is increased by 1.1°C in animals 
fed a LP diet, and that administration of norepinephrine is more 
efficient to increase the basal temperature (+0.2°C) in rats fed a 
LP diet when compared to rats fed a control diet (76).
The effect of LP and HP diets on total energy expenditure is 
mediated notably by a modulation of genes encoding uncoupling 
proteins (UCP). UCP are proton carriers that uncouple their 
return into the mitochondrial matrix for ATP production, thus 
decreasing energy production efficiency. The energy from sub-
strates oxidation is then dissipated as heat. Studies have reported 
an increase in UCP1 expression under LP (76) and HP diets 
(55). Another study found similar results in rats, showing that 
FiGURe 1 | effects of low protein (LP) and high protein (HP) diet on body composition, food intake, and energy expenditure.
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an increase in dietary protein intake is able to upregulate UCP2 
expression in the liver. These changes that are associated with 
increased abundance in UCP are positively correlated to energy 
expenditure (75).
Both the effects of LP and HP diet on UCP expressions could 
be modulated by the restriction or supplementation of specific 
AAs, for instance, histidine supplementation increases the con-
tent of UCP1 in brown adipose tissue (44, 45).
On the other hand, Malloy et al. have shown that the energy 
expenditure in rats fed with a methionine-deficient diet was 
greater than that of rats fed ad libitum or in animals pair-feed to 
a control diet (77). Consistent with these findings, other studies 
have shown that methionine restriction was accompanied by an 
increase in energy expenditure, including thermogenesis and 
body temperature increase (78, 79).
Interestingly, the consumption of both LP and HP diets results 
in an increase in energy expenditure. The effects of the two types 
of diets are summarized in Figure 1 below.
LP Diet and Protein Quality
Recent studies, using a new scoring system to qualify dietary 
protein quality, namely the digestible indispensable amino acid 
score (DIAAS), allowed a better comparison of protein quality. 
Indeed, this score is not truncated compared to usual systems 
used to evaluate protein quality like the nitrogen balance meas-
urement. DIAAS classification is based on the relative digestible 
content of the essential AAs. This classification shows that dairy 
proteins have the highest quality (80). In accordance with this 
classification, a study in human volunteers has shown that milk 
proteins are more efficient to stimulate muscle protein synthesis 
than soy protein. The best effectiveness of milk protein for such 
an effect was correlated to the higher proportion of leucine (81).
Evaluation of the so-called ideal protein level to better main-
tain health is complex. Most animal studies designed to evaluate 
the impact of LP diet on health barely took into account protein 
quality, and this may explain discrepancy between different stud-
ies. A recent review of Le Couteur et al. (82) suggests that LP diets 
generate longer lifespans in ad libitum-fed mice. Interestingly, the 
same results were obtained using the ad  libitum insect model, 
suggesting that these effects of LP diets apply to very different 
animal models. However, the protein leverage induced by LP 
diet, which increases food intake and fat deposition, is not always 
integrated. Restriction of particular AAs, such as methionine, 
has been shown to extend life duration in mice (83) and rat (84), 
and lower serum level of IGF-1, insulin, glucose, and thyroid 
hormone in serum (85).
A recent study using Balb/C mice under moderate protein 
restriction shown that protein quality is an important factor for 
biological effects. Ingestion of low quality protein that reduces 
IGF-1 serum level is related to decreased LBM and bone quality 
(86). This study included a group of control mice feed with a 
control soy-based normal protein diet including 20% of the total 
energy as soy protein (NP-SOY) and two other groups receiving 
LP diets. The first one was a soy-based protein restricted diet, with 
6% of the total energy as soy protein (LP-SOY), while the second 
one was a casein-based protein restricted diet with 6% of the total 
energy as casein (LP-CAS). To avoid the protein leverage effect, 
a pair-feeding group corresponding to the LP groups was used. 
As all the diets were isocaloric, the pair feeding allowed to ensure 
that energy intake was similar in all the groups.
Over the duration of the experiment (60  days), total body 
weight of LP-SOY mice remained at the baseline value, while 
NP-SOY and LP-CAS mice gained weight. The difference in total 
body weight was related to a lower lean mass gain in LP-SOY 
when compared to LP-CAS and NP-SOY mice. Reduction of 
IGF-1 plasma level and bone quality related to reduce bone 
formation was observed in the LP-SOY group (Table 1) (86).
The comparison of the effects of LP-SOY and LP-CAS diets 
on various parameters thus indicates that protein quality is of 
prime importance in the case of moderate protein restriction. 
The observed effects on body composition and blood plasma 
parameters could be partly related to a difference in AA profile, 
as casein is richer than soy primarily in methionine, and also in 
proline, serine, threonine, glutamine, valine, tyrosine, isoleucine, 
and leucine (87–89). Previous studies suggested that reduction of 
particular AAs in the diet can extend lifespan in mice and rats. 
However, this study shows that reduced IGF-1 level, which is 
correlated with reduction of bone formation and LBM includ-
ing uterus weight, do have adverse consequences on health 
parameters (86). This latter study shows that LBM response to 
nutritional interventions, particularly dietary protein quality, 
TABLe 1 | effect of a soy- or casein-based protein restriction on body 
composition, bone quality, and bone turnover markers after 60 days.
Diets
NP-soy Low-protein 
(LP)-CAS 6%
LP-soy 6%
Weight gain (g) 3.41 ± 0.48a 3.81 ± 0.36a 0.55 ± 0.40b
Lean mass gain (g) 2.05 ± 0.32a 1.57 ± 0.18a −0.63 ± 0.26b
Uterus (mg) 81 ± 5a 52 ± 3b 24 ± 1c
Femur cortical 
thickness (mm)
0.232 ± 0.003a 0.226 ± 0.002a 0.205 ± 0.002b
Femur length (mm) 15.72 ± 0.12a 15.62 ± 0.13a 15.00 ± 0.11a
Femoral BMD change 
(delta%)
14.5 ± 0.5a 13.8 ± 0.9a 6.7 ± 1.5b
IGF-1 325 ± 30a 302 ± 18a,b 247 ± 15b
PINP (bone formation 
marker)
1.76 ± 0.15a 1.30 ± 0.13a 0.65 ± 0.06b
Data are means ± SEM (n = 15). A one-way ANOVA followed by Bonferroni’s post hoc 
was performed. Means with different superscript letters (a, b, c) are significantly 
different (p < 0.05) according to a Bonferroni multiple comparison test (86).
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is a good marker of the minimal dietary protein needed in this 
experimental model. This endpoint may be especially important 
for the aging population, because reduced protein intake which is 
often observed in the elderly, and which reduces LBM and bone 
mass are associated with fracture, reduction of life quality, and 
lifespan. However, data in humans also indicate that reduced pro-
tein intake may become an important component of anticancer 
and antiaging dietary interventions (90, 91), indicating that LP 
intake may induce heterogeneous biological effects. As discussed 
earlier, the evaluation of the ideal protein level for optimal effect 
on the health maintenance is complex and needs thus the evalu-
ation of many health outcomes (80).
LP and HP Diet during Gestation, 
Lactation, and Perinatal Periods
The early-life period, starting even before birth, is a key deter-
minant of adult health. Environmental exposure, particularly 
nutrition, has a programming effect on later metabolic health.
Low protein and HP intakes during gestation and lactation 
are commonly viewed as stressors that can lead to changes in the 
body composition of the offspring.
Thus, it has been shown that feeding LP maternal diet during 
both gestation and lactation, or only during lactation, decreases 
the body weight and adiposity in both males and females (92, 93). 
By contrast, protein restriction only during gestation has no effect 
on males but leads to a lower LBM and higher body fat mass in 
females (93).
Interestingly, feeding pregnant rats with a LP diet results in a 
preference for high-fat foods in the offspring at the age of 12 weeks 
(94). In the same study, the authors reported that females, but not 
males, failed to adjust their energy intake and exhibited a higher 
adiposity. In line with these results, it was shown that a maternal 
LP diet results in low birth weight and subsequent adipose tissue 
catch-up growth when the offspring is fed a high-fat diet in male 
rats (95). Taken together, these results suggest that the exposition 
to a LP diet result in low birth weight and predispose to obesity 
when exposed to a high fat diet during the postnatal period.
Infant formulas have a higher protein content than breast 
milk, and the subsequent increase in protein intake of infants 
consuming formulas has been associated with increased risk of 
obesity (96). Thus, the impact of HP intake during the perinatal 
period needs further studies.
The effects of HP diet during gestation and lactation in animal 
models are controversial, leading to either no change or birth 
weight decrease (97–99). Likewise, HP diets can induce increase 
or decrease of body weight and adiposity (97, 100), depending on 
the experimental design.
High protein diets during gestation have been associated with 
higher adiposity and decreased energy expenditure in young male 
rats (101). Sex-specific effects of HP diets during both gestation 
and lactation predispose females, but not males, to higher body 
weight and adiposity (99, 102).
The protein source ingested by the mother during gestation 
and lactation can also influence body composition. Thus, it has 
been reported that when the maternal diet include soy protein, the 
offspring exhibit a higher body weight and adiposity compared to 
the offspring of dams fed with a casein-based diet. This is prob-
ably due to an alteration of food intake regulation in the offspring 
of dams fed a soy protein-based diet (103). Further experiments, 
including epigenetic modification measurement, are needed in 
order to decipher the underlying mechanisms explaining these 
latter results.
iMPACT OF eSTROGeN DeFiCieNCY ON 
BODY weiGHT AND PHYSiOLOGiCAL/
MeTABOLiC PARAMeTeRS: iMPACT OF 
DieTARY PROTeiN
The prevalence of metabolic syndrome, a constellation of abnor-
malities that includes obesity, hypertension, glucose intolerance, 
and dyslipidemia is higher in men than in women, but according 
to some epidemiological studies, this gender difference disap-
pears after menopause (104). Animal studies have also reported 
protection of female mice from development of diet-induced 
obesity compared to age-matched males (105). However, as 
mentioned earlier, this advantage is lost in women at menopause, 
and the estrogen level decline is associated with central adiposity, 
insulin resistance, decreased energy expenditure, and greater risk 
of cardiovascular diseases (106, 107). Estrogen withdrawal dur-
ing menopause is also associated with increased production of 
pro-inflammatory cytokines that are involved in many different 
diseases including osteoporosis, rheumatoid arthritis, and mul-
tiple myeloma (108). Figure  2 summarizes estrogen actions in 
the brain, adipose tissue, pancreatic islets, skeletal muscles, bone, 
liver, and macrophages, indicating the impact of estrogen on 
many tissues. These latter are known to act in synergy to promote 
glucose and lipid homeostasis.
As it is difficult, for obvious ethical reasons, to study in 
depth physiological and metabolic consequences of menopause 
in women, notably in a mechanistic perspective, surgical ova-
riectomy in animal models has been used to mimic estrogen 
deficiency. Ovariectomized (OVX) animal models have been 
widely used to study metabolic disorders associated with decrease 
FiGURe 2 | Summary of the consequence of impaired estrogen action on the physiology of many target organs.
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of estradiol secretion in order to evaluate pharmacological and 
nutritional treatments that can safely reduce the consequences of 
menopause. Indeed, the use of OVX rats or mice to simulate the 
postmenopausal conditions is well established and represents a 
reproducible model. Notably, OVX animal models mimic meta-
bolic modifications related to estrogen deficiency over a relatively 
short period of time. Witte et al. (109) showed that female rats 
and female mice do not have similar metabolic and behavioral 
responses after ovariectomy, demonstrating species differences in 
this experimental model. The OVX-induced weight gain in rats 
is mediated both by hyperphagia and reduced locomotor activity, 
while in mice the OVX procedure reduced locomotor activity and 
metabolic rate. Such species differences in response to OVX need 
to be taken into account when results are tentatively extrapolated 
to humans.
The most commonly used mice strain used to mimic conse-
quences of estrogen withdrawal are C57BL/6J mice and C3H/Hen 
mice. One of the main consequences of the OVX procedure is 
an increase in the body weight. Incidentally, those models have 
been setup to study not only consequences of estrogen deficiency 
on obesity but also on various diseases including cancer, osteo-
porosis, cardiovascular diseases, and inflammation. Using the 
OVX C3H/Hen mice model to induce bone loss, studies (88, 
89) have shown that even when the surgery was performed at 3 
or 6 months, the procedure induced an increase in body weight 
related to an increase in the visceral and subcutaneous fat mass. 
However, when the OVX procedure was performed at 6 months, 
reduction of uterus weight was not observed compared to Sham 
mice. The spontaneous uterine atrophy observed in older Sham 
mice explains the absence of measurable difference. In the same 
study, the effect of raloxifene, a drug commonly indicated for 
osteoporosis which activates estrogen receptor (ER), prevented 
bone loss and the increase in body weight and fat mass observed 
following the OVX procedure (Table  2). However, raloxifene 
supplementation was not able to inhibit uterus weight loss. The 
preventive effect of raloxifene on weight gain in OVX C3H/Hen 
mice is in agreement with a recent study showing, in another 
mouse model, that selective activation of ER positively regulates 
mice metabolism (110).
Mutations of ER are correlated to different aspects of the 
metabolic syndrome. Reduced ERα levels in the adipose tissue 
of obese individuals compared to the non-obese counterparts 
support a role of estrogen signaling in the control of body weight 
(112). The impact of ER activation on metabolic dysfunction 
related to menopause has also been studied using mice strain 
with a specific deletion of the ERα. Those mice become obese, 
glucose intolerant, hyperinsulinemeic and have decreased energy 
expenditure, decreased locomotion, and increased secretion of 
pro-inflammatory factors. The fat mass increase is associated not 
only with a decrease of the energy expenditure and of fat oxida-
tion but also with an elevation of the circulating inflammatory 
markers (113, 114). Consequences of ERα deletion or ovariec-
tomy are similar, supporting that ERα regulates mice energy 
metabolism (113). Moreover, loss of ERα in the central nervous 
system has been shown to induce hyperphagia and to decrease 
energy expenditure (115). Estradiol (E2), the major biologically 
active form of estrogen, is also known to positively influence 
insulin action in mice (113). Moreover, estrogen protection 
of female mice from development of diet-induced obesity and 
insulin resistance compared to age-matched males has also been 
demonstrated (105). A recent study using the ovariectomized 
mice model has shown that stimulation of estradiol receptor 
TABLe 2 | effect of ovariectomy, hormone replacement, or lactoferrin supplementation in OXv mice on body composition and bone mineral density 
after 12 weeks.
Groups
Sham OvX OvX + raloxifene OvX + LF
Initial body weight (g) 25.14 ± 1.18 24.20 ± 1.43 24.32 ± 1.06 24.70 ± 2.06
Final body weight (g) 35.50 ± 2.34a 41.74 ± 2.49b 34.61 ± 2.86a 42.68 ± 3.39b
Weight gain (g) 10.36 ± 1.84a 17.54 ± 2.21b 10.29 ± 1.43a 17.98 ± 2.48b
Uterus (mg) 253 ± 41a 131 ± 29b 127 ± 28b 160 ± 28b
Fat mass (g) 7.23 ± 1.63a 12.32 ± 2.03b 8.25 ± 1.35a 12.54 ± 2.15b
Carcass (g) 11.37 ± 0.59 12.87 ± 1.17 11.84 ± 0.72 12.54 ± 1.57
BMD gain (mg/cm2) 13 ± 2 8 ± 3a 13 ± 2 13 ± 2
The surgery was performed on 12-week-old C3H mice. Data are means ± SEM (n = 10). A one-way ANOVA followed by Bonferroni’s post hoc was performed. Means with different 
superscript letters (a, b) are significantly different (p < 0.05) according to a Bonferroni multiple comparison test [adapted from Ref. (88, 89, 111)].
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prevents weight gain, insulin resistance, and improved systemic 
metabolism.
Food intake and spontaneous physical activity have been 
measured in OVX C3H/Hen mice, and both parameters were 
reduced compared to Sham mice (Figure 3). As the spontaneous 
physical activity reduction of the OVX mice is able to explain only 
a small part of the reduced ingestion, it is likely that the increased 
body weight and adiposity is related to a 15% decrease of the rest-
ing metabolism in the OVX mice. The absence of increased food 
intake and the reduced metabolic rate have also been reported 
in C57BL/6J mice (109). However, in mice lacking ERα in the 
central nervous system, a hyperphagia and decreased energy 
expenditure have been reported (115).
Moreover, using OVX C3H/Hen mice, it has been also pos-
sible to demonstrate that the OVX procedure is associated with 
immunological dysregulation. Indeed, Malet et al. (111) shown 
that estrogen deficiency induces heightened immune response 
sensitivity and an inflammatory status that were correlated to bone 
loss. Estrogen withdrawal is associated with T cell activation that 
produces essential osteoclastic factor such as RANKL and TNFα 
(108, 116). Lactoferrin (LF) ingestion has been shown to reduce 
T cell activation, pro-inflammatory cytokines, and consequently 
bone loss (111). Interestingly, LF is as efficient as raloxifene for 
the maintenance of bone mineral density in OVX mice, but did 
not reduce weight gain. However, neither compounds were able 
to preserve uterus weight (Table 2).
The menopause transition is associated not only with an 
increase in total body fat mass, visceral fat mass, and decreased 
energy expenditure but also with the increase of many inflam-
matory markers. Such an increase has indeed consequences on 
the incidence of many other pathologies including osteoporosis. 
However, obesity has been considered to have some beneficial 
effects for bone health in humans by some authors (117). The 
increase body weight and the ability of adipose tissue to synthe-
size estrogen support this proposition (118, 119). Since it has 
been proposed that estrogen synthesized by adipose tissue may 
have some antiresorptive effect on bone, Cao and Gregoire (120) 
studied the effect of high-fat diet on bone quality in OVX mice. 
This study shows that OVX mice fed with a high-fat diet, gain 
more weight, and had a higher estradiol level than mice feed with 
a standard diet, raising the question of the origin of estradiol 
production. However, the high-fat diet was not able to mitigate 
the OVX-induced bone loss in mice. Then, authors proposed that 
estrogen, likely synthesized by adipose tissue, does not have the 
same antiresorptive effect on bone as estrogen secreted by ovaries.
Those studies indicate that many non-elucidated mechanisms 
are involved in energy homeostasis in OVX mice. However, as 
OVX mice have a reduced energy expenditure similar to the one 
observed in estrogen-deficient women, it appears that mice is a 
useful model in that topic. Regarding the effect of dietary protein 
on dysfunctions related to ovariectomy, there is a relative paucity 
of available data. It has been shown that supplementation with 
water-insoluble fish protein has a cholesterol lowering effect in 
ovariectomized rats (121). Another dietary protein source, that is 
soybean extract, has been found to modulate the level of serum 
TGs in ovariectomized rats fed a cholesterolemic diet (122).
THe PiG MODeL FOR ReSeARCH ON 
OBeSiTY
Regarding extrapolation to human situations, it is worth not-
ing that the pig model is often considered as a model closer 
to humans than rodents for several aspects of physiological 
and metabolic studies. Indeed, the pig model has emerged as a 
relevant non-primate experimental animal for extrapolation to 
humans because of numerous similarities regarding anatomy, 
development, nutrition, and physiology (123–126). Pigs are 
also an animal model that is truly omnivorous, which make 
spontaneously individual meals, and which display striking 
similarities with humans in terms of nutritional requirements 
(127). It is also worth noting that the gut in the newborn pigs, 
although more mature that in newborn rodents, is, however, 
less mature than in infants (128). Another advantage of the pig 
model is that it is possible to recover a large number of cells (for 
instance, absorptive intestinal cells from both the small and large 
intestine after dietary intervention), even in young animals, 
in order to measure the impact of such intervention on cell 
metabolism and physiology (129, 130). In the pig model, preterm 
delivery at 90% gestation is comparable to preterm infant born 
at approximately 75% gestation (30 weeks) (131), making the pig 
neonate an interesting model for pediatric studies. In contrast 
to the rodent models, the size of newborn pig easily allows for 
tissue sampling and experimental manipulations of nutritional, 
FiGURe 3 | Daily food intake analysis (A) and spontaneous physical activity (B) of Sham and OvX performed 10 weeks after the OvX procedure. Data 
are means ± SEM (n = 8). Groups with different letters are significantly different (p < 0.05).
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physiological, and metabolic conditions. Finally, the pig model 
allows multi-catheterization and blood sampling without anemia 
thus allowing kinetics experiments (132).
However, even if the mini pig models, although relatively 
expensive, are increasingly used for research projects notably 
due to their limited size compared to regular farm pigs, the pig 
model present some drawbacks since it requires extensive areas 
for breeding, and is a source of abundant polluting compounds 
in biological fluids (fecal matter and urine), a situation incom-
patible with the use of the pig model in urban areas. As a matter 
of fact, in PubMed, the number of articles related to pig and 
obesity (798 articles) represents only about 2% of the number 
of articles related to rats/mice and obesity (35,318 articles). 
The readers are invited to refer to recent reviews regarding the 
pig model used for studies regarding the genetics of adiposity 
(133), the obese type 2 diabetes (134), the dietary modulation 
of gut microbiota and possible impact on obesity (135), the 
gastrointestinal hormones for eating control (136), and finally 
the establishment of food preferences and aversions (123) since 
these aspects will not be developed in this review. Regarding 
the specific aspect of the impact of the quantity and quality of 
dietary proteins on the gastrointestinal health in pigs, it has been 
shown that intestinal fermentation of the proteins results in the 
production of various potentially deleterious luminal products, 
which is often associated with growth of potential pathogens. In 
fact, excessive dietary protein intake (that mimic HP slimming 
diet) has been shown to stimulate in the pig model the growth of 
Clostridium perfringens and to reduce fecal counts of beneficial 
Bifidobacteria (137).
An increasing number of studies in pigs indicates that the 
gastrointestinal health is influenced by both the composition 
of the intestinal microbiota and its metabolic activity (138), 
this latter being impacted by the dietary composition, notably 
in terms of quantity and quality of dietary proteins (139). 
Indeed, the protein digestibility and protein AA composition 
are parameters that impact the profile of AA-derived bacterial 
metabolites in the large intestine. The use of fermentable car-
bohydrates to reduce deleterious protein-derived bacterial 
metabolites in pigs is well established (140), and for instance, 
soybean oligosaccharides have been shown to increase the 
presumably beneficial short-chain fatty acids while decreasing 
the protein-derived catabolites in the intestinal luminal con-
tent in weaned piglets (141). Last, interesting data have been 
recently obtained regarding the impact of the amount of dietary 
protein consumed by pigs on parameters like expression of AA 
and peptide transporters (125), or signaling pathways related 
to protein synthesis in muscles (142). Then, from these exam-
ples, it appears that using pig models for confirmation of data 
obtained in rodents represents a useful experimental strategy 
before further development of clinical studies implying dietary 
intervention with human volunteers, notably in overweight and 
obese individuals.
CONCLUSiON AND PeRSPeCTiveS
Animal models are necessary in order to understand the mecha-
nisms underlying the various biological parameters involved in 
the risk of obesity. Even if it is recognized that obesity results 
primarily from higher long-term energy consumption than 
energy expenditure, notably in case of low level of physical activ-
ity, we present here two situations in which animal models have 
been useful to understand how dietary (quantity and quality 
of dietary proteins) and physiological (menopause) modifica-
tions can impact parameters closely related to the development 
of obesity including body composition, food intake, energy 
expenditure, and tissue metabolism and physiology. Future 
research, notably in terms of mechanisms of action, using rel-
evant animal models on the impact of dietary modifications at 
the different periods of age (notably during gestation, lactation, 
and perinatal periods of life) should allow to better enlighten 
on the best strategy for limiting the risk of obesity in young and 
aging adults.
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